Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Global Blood Therapeutics Inc. (GBT)

64.43   -2.54 (-3.79%) 02-25 16:00
Open: 67.43 Pre. Close: 66.97
High: 68.22 Low: 63.64
Volume: 652,240 Market Cap: 3881M
Global Blood Therapeutics Inc is a clinical-stage biopharmaceutical company in the United States. Its major focus lies on developing therapeutics for the treatment of blood-based disorders such as red blood cell sickling.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 68.365 - 68.776 68.776 - 69.082
Low: 62.704 - 63.224 63.224 - 63.61
Close: 63.745 - 64.515 64.515 - 65.087

Technical analysis

as of: 2020-02-25 4:29:53 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 88.04     One year: 97.84
Support: Support1: 61.80    Support2: 51.42
Resistance: Resistance1: 75.38    Resistance2: 83.77
Pivot: 71.25
Moving Average: MA(5): 69.71     MA(20): 70.33
MA(100): 65.25     MA(250): 58.67
MACD: MACD(12,26): -1.74     Signal(9): -1.33
Stochastic oscillator: %K(14,3): 37.26     %D(3): 57.02
RSI: RSI(14): 33.97
52-week: High: 87.54  Low: 44.17  Change(%): 21.4
Average Vol(K): 3-Month: 108433  10-Days: 55390

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
GBT has closed below the lower band by 18.6%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 26.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Guerbet Announces Appointment of Thomas McLaughlin as Vice President for North America
PRINCETON, N.J., Jan. 8, 2020 /PRNewswire/ -- Guerbet, a global specialist in contrast agents and solutions for medical imaging, announced today that Thomas McLaughlin has been appointed Vice President, North America. In this role, McLaughlin will oversee and ensure the growth of Guerbet…

Global Blood (GBT) Shares Double in a Year, Focus on Oxbryta
Shares of Global Blood Therapeutics (GBT) have gained in the past year as its lead candidate voxelotor gets FDA approval for the treatment of SCD in patients aged 12 years or above.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 60.23
Shares Float (M) 52.87
% Held by Insiders 63.07
% Held by Institutions 13.26
Shares Short (K) 7890
Shares Short P. Month (K)

Stock Financials

EPS -3.890
Book Value (p.s.) 10.930
PEG Ratio -0.46
Profit Margin
Operating Margin
Return on Assets (ttm) -23.6
Return on Equity (ttm) -38.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -3.873
Qtrly Earnings Growth
Operating Cash Flow (M) -165.65
Levered Free Cash Flow (M) -97.01

Stock Valuations

P/E -16.56
P/E Growth Ratio -0.04
P/BV 5.89
P/CF -23.43

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.